Optimise your bioproduction path by effectively applying disposable systems to capture cost benefits and increase facility flexibility

Pharma IQ is delighted to announce the dates for the 2nd Annual Disposable Solutions for Biomanufacturing taking place in London on the 23rd-24th February 2010. The use of single-use systems within bioprocessing and manufacturing is one area within the pharmaceutical industry that constantly sees exciting developments and this year is no exception.

Conference Chairmen:

Robert-Repetto

Robert Repetto
Director, Global New Technology and Innovation, Wyeth Biotech.
Chair, Single-Use Systems Task Force, PDA

Jerold-Martin

Jerold Martin
Chairman, Bioprocess Systems Alliance, Senior Vice President, Scientific Affairs
Pall Life Sciences

Key Speakers Include:

Dr Stephen Brown
Chief Technical Officer, Vivalis. Member,
Single Use Task Force, PDA

Jay Thompson
Associate Director, Biologicals Development
Pfizer Inc.

Morten Munk
Vice President, Business Development, Technology Specialist
CMC Biologics A/S. Co-Chair, Single-Use Systems Task Force, PDA

For full speaker list click here

Critical Topics to be Discussed Include:

Uncover how you can leverage the experience you and others have already gained working with single use systems for future facility designs: Eli Lilly & Co. will be sharing with you the applications they have successfully used disposables at their clinical trials plant in Indianapolis and how their lessons learned have helped them and can help you when approaching new single use applications.
Establish a well defined strategy for applying disposables within a broader Quality by Design programme: Wyeth Biotech will be sharing with you some of the approaches taken by Wyeth in this field as well as the possibilities for the future.
Successfully apply a risk based approach when implementing disposable technology: Vivalis will be discussing how they applied a risk based approach when selecting and implementing the disposable systems use in IMP manufacture.
Design and implement an end-to-end single-use system: GlaxoSmithKline will discuss how they implemented an end-to-end system for final fill of Drug Substance, the benefits they have seen and how you could dot he same.

What did your peers think...?

Very good mixture of different aspects, interesting case studies.

Rene Brecht, Vice President of Process Science and Manufacturing, Pro Bio Gen AG

Very valuable.

Eilis Murphy, Nibet

As a supplier it's great to get our customers perspective on future.

Jim Carswell, Invitrogen

Last year's event was an excellent conference with expert comment on many key issues related specifically to implementation of singe-use technologies within the industry. We are therefore committed to the 2009 event to enable further networking, discussion and understanding of the key requirements for technology development within single-use operations as well as to promote our portfolio and capabilities within this area. IQPC delivered an excellent event, with first rate organisation and a good combination of concise presentations delivered by experienced presenters on relevant topics. We'll be back!

Bruce Rawlings, Pall Life Sciences